glycyl-arginyl-glycyl-aspartyl-serine and Vascular Diseases

glycyl-arginyl-glycyl-aspartyl-serine has been researched along with Vascular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
He, Y; Li, H; Maharjan, A; Ren, X; Su, Y; Sun, X; Xu, J; York, P; Zhang, J	1

Other Studies

1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-serine and Vascular Diseases

Article	Year
Cuboidal tethered cyclodextrin frameworks tailored for hemostasis and injured vessel targeting. Theranostics, 2019, Volume: 9, Issue:9 Topics: Animals; Blood Platelets; Cell Adhesion; Cyclodextrins; Disease Models, Animal; Drug Delivery Systems; Hemorrhage; Hemostasis; Mice; Oligopeptides; Organometallic Compounds; Platelet Aggregation; Rats, Sprague-Dawley; Theranostic Nanomedicine; Treatment Outcome; Vascular Diseases	2019

Article

Year

Cuboidal tethered cyclodextrin frameworks tailored for hemostasis and injured vessel targeting.

Theranostics, 2019, Volume: 9, Issue:9

Topics: Animals; Blood Platelets; Cell Adhesion; Cyclodextrins; Disease Models, Animal; Drug Delivery Systems; Hemorrhage; Hemostasis; Mice; Oligopeptides; Organometallic Compounds; Platelet Aggregation; Rats, Sprague-Dawley; Theranostic Nanomedicine; Treatment Outcome; Vascular Diseases

2019